4//SEC Filing
Bellon Christine 4
Accession 0000950170-23-065868
CIK 0001745999other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:05 PM ET
Size
13.2 KB
Accession
0000950170-23-065868
Insider Transaction Report
Form 4
Bellon Christine
Chief Legal Officer
Transactions
- Sale
Common Stock
2023-11-20$31.00/sh−5,000$155,000→ 82,402 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-20−5,818→ 10,918 totalExercise: $7.22Exp: 2029-05-17→ Common Stock (5,818 underlying) - Exercise/Conversion
Common Stock
2023-11-20$7.22/sh+4,182$30,194→ 86,584 total - Exercise/Conversion
Common Stock
2023-11-20$7.22/sh+5,818$42,006→ 92,402 total - Sale
Common Stock
2023-11-20$30.00/sh−5,000$150,000→ 87,402 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-20−4,182→ 9,492 totalExercise: $7.22Exp: 2029-05-16→ Common Stock (4,182 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
- [F2]The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
- [F3]The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001963878
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:05 PM ET
- Size
- 13.2 KB